Ampio Pharmaceuticals (FRA:APH0) Cyclically Adjusted FCF per Share: €-150.96 (As of Dec. 2023)


FRA:APH0 Ampio Pharmaceuticals Inc FRA:APH0
35 GF Score
Price €3.62
View Full Analysis

What is Ampio Pharmaceuticals Cyclically Adjusted FCF per Share?

Ampio Pharmaceuticals FRA:APH0 35 Cyclically Adjusted FCF per Share is €-150.96 as of Dec. 2023. GuruFocus rates FRA:APH0 with a GF Score™ of 35/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Ampio Pharmaceuticals's adjusted free cash flow per share for the three months ended in Dec. 2023 was €-2.557. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-150.96 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-10), Ampio Pharmaceuticals's current stock price is €3.62. Ampio Pharmaceuticals's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was €-150.96. Ampio Pharmaceuticals's Cyclically Adjusted Price-to-FCF of today is .


Ampio Pharmaceuticals  (FRA:APH0) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Ampio Pharmaceuticals Cyclically Adjusted FCF per Share Related Terms


Ampio Pharmaceuticals Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Ampio Pharmaceuticals's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ampio Pharmaceuticals Cyclically Adjusted FCF per Share Chart

Ampio Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.44 -5.58 -5.86 -20.75 -150.96

Ampio Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.75 -19.59 -83.22 -90.69 -150.96

FRA:APH0 vs EFTR, VBIVQ, VRTX: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Ampio Pharmaceuticals's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ampio Pharmaceuticals Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ampio Pharmaceuticals's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Ampio Pharmaceuticals's Cyclically Adjusted Price-to-FCF falls into.


FRA:APH0
35GF Score
Ampio Pharmaceuticals Inc FRA:APH0
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ampio Pharmaceuticals Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ampio Pharmaceuticals's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-2.557/306.7460*306.7460
=-2.557

Current CPI (Dec. 2023) = 306.7460.

Ampio Pharmaceuticals Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -55.553 236.293 -72.117
201406 -53.566 238.343 -68.939
201409 -39.399 238.031 -50.773
201412 -30.509 234.812 -39.855
201503 -37.653 236.119 -48.916
201506 -28.156 238.638 -36.192
201509 -32.295 237.945 -41.633
201512 -41.220 236.525 -53.458
201603 -25.353 238.132 -32.658
201606 -23.988 241.018 -30.530
201609 -12.436 241.428 -15.801
201612 -12.812 241.432 -16.278
201703 -12.916 243.801 -16.251
201706 -13.599 244.955 -17.029
201709 -11.626 246.819 -14.449
201712 -8.824 246.524 -10.980
201803 -11.145 249.554 -13.699
201806 -8.977 251.989 -10.928
201809 -7.263 252.439 -8.825
201812 -0.381 251.233 -0.465
201903 -5.846 254.202 -7.054
201906 -7.740 256.143 -9.269
201909 -9.076 256.759 -10.843
201912 -8.237 256.974 -9.832
202003 -7.701 258.115 -9.152
202006 -7.344 257.797 -8.738
202009 -3.861 260.280 -4.550
202012 -3.793 260.474 -4.467
202103 -5.308 264.877 -6.147
202106 -2.879 271.696 -3.250
202109 -4.967 274.310 -5.554
202112 -4.388 278.802 -4.828
202203 -5.954 287.504 -6.352
202206 -7.462 296.311 -7.725
202209 -7.960 296.808 -8.227
202212 -5.377 296.797 -5.557
202303 -2.846 301.836 -2.892
202306 -4.155 305.109 -4.177
202309 -0.647 307.789 -0.645
202312 -2.557 306.746 -2.557

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-150.96 mean?
Ampio Pharmaceuticals (FRA:APH0) has a Cyclically Adjusted FCF per Share of €-150.96 as of Dec. 2023. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Ampio Pharmaceuticals and its competitors.
Is Ampio Pharmaceuticals' Cyclically Adjusted FCF per Share too high?
Ampio Pharmaceuticals' current Cyclically Adjusted FCF per Share is €-150.96. Overall, Ampio Pharmaceuticals has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Ampio Pharmaceuticals' Cyclically Adjusted FCF per Share compare to EFTR and VBIVQ?
Ampio Pharmaceuticals' Cyclically Adjusted FCF per Share of €-150.96 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Ampio Pharmaceuticals and its competitors. Ampio Pharmaceuticals's current Cyclically Adjusted FCF per Share is €-150.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ampio Pharmaceuticals stock overvalued right now?
Ampio Pharmaceuticals (FRA:APH0) has a current Cyclically Adjusted FCF per Share of €-150.96. The current Cyclically Adjusted FCF per Share is €-150.96. Ampio Pharmaceuticals' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Ampio Pharmaceuticals (FRA:APH0), the current Cyclically Adjusted FCF per Share is €-150.96 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ampio Pharmaceuticals Business Description

Address 9800 Mount Pyramid Court, Suite 400, Englewood, CO, USA, 80112
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee (OAK) as part of its OA-201 development program (OA-201 program or OA-201).
35GF Score

Get the complete analysis for FRA:APH0

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.62
Price